|
COG8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.143300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.442700E-03 |
| Normal-vs-Stage2 |
6.436000E-01 |
| Normal-vs-Stage3 |
1.356320E-03 |
| Normal-vs-Stage4 |
1.984420E-02 |
| Stage1-vs-Stage2 |
7.439700E-02 |
| Stage1-vs-Stage3 |
1.199800E-01 |
| Stage1-vs-Stage4 |
5.021200E-01 |
| Stage2-vs-Stage3 |
1.506260E-02 |
| Stage2-vs-Stage4 |
9.239800E-02 |
| Stage3-vs-Stage4 |
6.673200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.101300E-03 |
| Normal-vs-AfricanAmerican |
4.154000E-01 |
| Normal-vs-Asian |
3.582400E-02 |
| Caucasian-vs-AfricanAmerican |
3.034200E-01 |
| Caucasian-vs-Asian |
9.188200E-01 |
| AfricanAmerican-vs-Asian |
3.589800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.178100E-03 |
| Normal-vs-Female |
1.390500E-02 |
| Male-vs-Female |
2.131200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.074360E-02 |
| Normal-vs-Age(41-60Yrs) |
2.463500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.556000E-02 |
| Normal-vs-Age(81-100Yrs) |
5.819700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.816200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.076200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.346000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.354600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.706400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.746800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.334400E-02 |
| Classical-VS-Follicular |
5.388400E-01 |
| Classical-VS-Other |
1.942050E-01 |
| Classical-VS-Normal |
2.485800E-02 |
| Tall-VS-Follicular |
2.155200E-01 |
| Tall-VS-Other |
6.651000E-01 |
| Tall-VS-Normal |
3.178100E-03 |
| Follicular-VS-Other |
3.821600E-01 |
| Follicular-VS-Normal |
3.416200E-02 |
| Other-VS-Normal |
5.271600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.621500E-02 |
| Normal-vs-N1 |
1.371840E-04 |
| N0-vs-N1 |
5.943800E-03 |
|
|
